Search by Drug Name or NDC
NDC 63323-0806-50 Fentanyl Citrate 0.05 mg/mL Details
Fentanyl Citrate 0.05 mg/mL
Fentanyl Citrate is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is FENTANYL CITRATE.
Product Information
| NDC | 63323-0806 |
|---|---|
| Product ID | 63323-806_a3532e70-055b-479d-9b5a-bc56b7eb3101 |
| Associated GPIs | 65100025102007 65100025102012 65100025102022 65100025102037 65100025102042 |
| GCN Sequence Number | 041385 |
| GCN Sequence Number Description | fentanyl citrate/PF VIAL 50 MCG/ML INJECTION |
| HIC3 | H3H |
| HIC3 Description | OPIOID ANALGESIC, ANESTHETIC ADJUNCT AGENTS |
| GCN | 32807 |
| HICL Sequence Number | 025386 |
| HICL Sequence Number Description | FENTANYL CITRATE/PF |
| Brand/Generic | Generic |
| Proprietary Name | Fentanyl Citrate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Fentanyl Citrate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 0.05 |
| Active Ingredient Units | mg/mL |
| Substance Name | FENTANYL CITRATE |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
| DEA Schedule | CII |
| Marketing Category | ANDA |
| Application Number | ANDA210762 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0806-50 (63323080650)
| NDC Package Code | 63323-806-50 |
|---|---|
| Billing NDC | 63323080650 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-806-50) / 50 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2019-05-03 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.62644 |
| Pricing Unit | ML |
| Effective Date | 2022-04-20 |
| NDC Description | FENTANYL 2,500 MCG/50 ML VIAL |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis